uses JavaScript to provide the best possible experience for our content, but your browser has it disabled. Learn how to enable it here.


Posted February 1, 2018

Seller of Supplements for Opiate Withdrawal Warned for Drug Claims

On January 11, 2018, the FDA sent warning letters to ten sellers of supplements promoted to treat opiate withdrawal following reviews of the companies' websites and social media which found statements and testimonials made about the products to be drug claims.

To see the warning letter for each product, click on the name below.

According to the FDA's warning letters, "the Acting Secretary of the Health and Human Services Department...has determined that a public health emergency exists nationwide involving the opioid crisis, the marketing and sale of unapproved opioid addiction treatment products is a potentially significant threat to the public health. Therefore, FDA is taking urgent measures to protect consumers from products that, without approval by FDA, claim to diagnose, mitigate, prevent, treat or cure opioid addiction." 

See related warnings:

36 Deaths Associated With the Use of Kratom Products

FTC Charges Maker of Supplement for Opiate Addiction with Deceptive Claims

Abnormal Heart Rhythms Linked with Unauthorized Natural Product, Health Canada Warns

Seller of B Vitamins, CoQ10, Amino Acids and Other Supplements Warned for Manufacturing Violations and Drug Claims

To see other recent recalls and warnings, use the link below.